Acetaminophen First-Line OA Treatment Guidelines Questioned In Study
This article was originally published in The Tan Sheet
Executive Summary
"Widespread emphasis" on acetaminophen use in patients with osteoarthritis should be reconsidered absent "larger scale, randomized, placebo-controlled trials" of the OTC analgesic in patients with knee OA, Chicago researchers say in the Jan. 27 issue of the Archives of Internal Medicine
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning